{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:26:47Z","timestamp":1775003207036,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Turkish Scientific and Technical Research Council","award":["214S170"],"award-info":[{"award-number":["214S170"]}]},{"name":"Istanbul University Scientific Research Projects","award":["27970"],"award-info":[{"award-number":["27970"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13760-017-0796-5","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T15:47:19Z","timestamp":1495727239000},"page":"841-848","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study"],"prefix":"10.1007","volume":"117","author":[{"given":"Murat Mert","family":"Atmaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Erdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerses","family":"Bebek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Baykan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candan","family":"Gurses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"796_CR1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp.69.6.711","volume":"69","author":"J Palace","year":"2000","unstructured":"Palace J, Lang B (2000) Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 69:711\u2013714","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"796_CR2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","volume":"65","author":"K McKnight","year":"2005","unstructured":"McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730\u20131736","journal-title":"Neurology"},{"key":"796_CR3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e32833735fe","volume":"23","author":"A Vincent","year":"2010","unstructured":"Vincent A, Irani SR, Lang B (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 23:144\u2013150","journal-title":"Curr Opin Neurol"},{"key":"796_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","volume":"13","author":"E Tuzun","year":"2007","unstructured":"Tuzun E, Dalmau J (2007) Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13:261\u2013271","journal-title":"Neurologist"},{"key":"796_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-1211(00)00180-7","volume":"42","author":"P Kwan","year":"2000","unstructured":"Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191\u2013195","journal-title":"Epilepsy Res"},{"key":"796_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","volume":"71","author":"HJ Majoie","year":"2006","unstructured":"Majoie HJ, de Baets M, Renier W, Lang B, Vincent A (2006) Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 71:135\u2013141","journal-title":"Epilepsy Res"},{"key":"796_CR7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","volume":"54","author":"T Brenner","year":"2013","unstructured":"Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54:1028\u20131035","journal-title":"Epilepsia"},{"key":"796_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","volume":"51","author":"S Liimatainen","year":"2010","unstructured":"Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A, Peltola J (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760\u2013767","journal-title":"Epilepsia"},{"key":"796_CR9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/epi.12528","volume":"55","author":"E Ekizoglu","year":"2014","unstructured":"Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414\u2013422","journal-title":"Epilepsia"},{"key":"796_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","volume":"69","author":"AM Quek","year":"2012","unstructured":"Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69:582\u2013593","journal-title":"Arch Neurol"},{"key":"796_CR11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1468-1331.2004.00943.x","volume":"11","author":"RF Chin","year":"2004","unstructured":"Chin RF, Neville BG, Scott RC (2004) A systematic review of the epidemiology of status epilepticus. Eur J Neurol 11:800\u2013810","journal-title":"Eur J Neurol"},{"key":"796_CR12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus\u2014Report of the ILAE task force on classification of status epilepticus. Epilepsia 56:1515\u20131523","journal-title":"Epilepsia"},{"key":"796_CR13","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511526930","volume-title":"Status epilepticus: its clinical features and treatment in children and adults","author":"SD Shorvon","year":"1994","unstructured":"Shorvon SD (1994) Status epilepticus: its clinical features and treatment in children and adults. Cambridge University Press, Cambridge"},{"key":"796_CR14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, Meyers E, Espinera A, Haas KF, Schmitt SE, Gerard EE, Gofton T, Kaplan PW, Lee JW, Legros B, Szaflarski JP, Westover BM, LaRoche SM, Hirsch LJ (2015) New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 85:1604\u20131613","journal-title":"Neurology"},{"key":"796_CR15","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1468-1331.2009.02839.x","volume":"17","author":"V Nociti","year":"2010","unstructured":"Nociti V, Frisullo G, Tartaglione T, Patanella AK, Iorio R, Tonali PA, Batocchi AP (2010) Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol 17:e5","journal-title":"Eur J Neurol"},{"key":"796_CR16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","volume":"49","author":"IC Kanter","year":"2008","unstructured":"Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ, Schellinger PD, Schwab S, Bardutzky J (2008) Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 49:914\u2013920","journal-title":"Epilepsia"},{"key":"796_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/1550059412459330","volume":"44","author":"U Cikrikcili","year":"2013","unstructured":"Cikrikcili U, Ulusoy C, Turan S, Yildiz S, Bilgic B, Hanagasi H, Baykan B, Tuzun E, Gurvit H (2013) Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody. Clin EEG Neurosci 44:232\u2013236","journal-title":"Clin EEG Neurosci"},{"key":"796_CR18","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/WNL.0b013e3182143552","volume":"76","author":"J Suleiman","year":"2011","unstructured":"Suleiman J, Brenner T, Gill D, Brilot F, Antony J, Vincent A, Lang B, Dale RC (2011) VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 76:1252\u20131255","journal-title":"Neurology"},{"key":"796_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000341143","volume":"68","author":"FJ Holzer","year":"2012","unstructured":"Holzer FJ, Rossetti AO, Heritier-Barras AC, Zumsteg D, Roebling R, Huber R, Lerche H, Kiphuth IC, Bardutzky J, Bien CG, Troger M, Schoch G, Pruss H, Seeck M (2012) Antibody-mediated status epilepticus: a retrospective multicenter survey. Eur Neurol 68:310\u2013317","journal-title":"Eur Neurol"},{"key":"796_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000001717","volume":"85","author":"M Spatola","year":"2015","unstructured":"Spatola M, Novy J, Du Pasquier R, Dalmau J, Rossetti AO (2015) Status epilepticus of inflammatory etiology: a cohort study. Neurology 85:464\u2013470","journal-title":"Neurology"},{"key":"796_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","volume":"40","author":"DH Lowenstein","year":"1999","unstructured":"Lowenstein DH, Bleck T, Macdonald RL (1999) It\u2019s time to revise the definition of status epilepticus. Epilepsia 40:120\u2013122","journal-title":"Epilepsia"},{"key":"796_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.wnp.0000220837.99490.66","volume":"23","author":"PW Kaplan","year":"2006","unstructured":"Kaplan PW (2006) The EEG of status epilepticus. J Clin Neurophysiol 23:221\u2013229","journal-title":"J Clin Neurophysiol"},{"key":"796_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/archneur.1977.00500170020003","volume":"34","author":"JE Thomas","year":"1977","unstructured":"Thomas JE, Reagan TJ, Klass DW (1977) Epilepsia partialis continua. A review of 32 cases. Arch Neurol 34:266\u2013275","journal-title":"Arch Neurol"},{"key":"796_CR24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348\u2013355","journal-title":"Eur J Neurol"},{"key":"796_CR25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667","journal-title":"Brain"},{"key":"796_CR26","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133:2734\u20132748","journal-title":"Brain"},{"key":"796_CR27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","volume":"84","author":"P Pettingill","year":"2015","unstructured":"Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A, Malaspina A, Jacob A, Irani SR, Buckley C, Beeson D, Lang B, Waters P, Vincent A (2015) Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology 84:1233\u20131241","journal-title":"Neurology"},{"key":"796_CR28","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"796_CR29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0013-9580.2004.09004.x","volume":"45","author":"HG Wieser","year":"2004","unstructured":"Wieser HG (2004) ILAE, Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45:695\u2013714","journal-title":"Epilepsia"},{"key":"796_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1059-1311(97)80037-4","volume":"6","author":"BA Engelsen","year":"1997","unstructured":"Engelsen BA, Gronning M (1997) Epileptic seizures in patients with multiple sclerosis. Is the prognosis of epilepsy underestimated? Seizure 6:377\u2013382","journal-title":"Seizure"},{"key":"796_CR31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archneurol.2009.5","volume":"66","author":"P Niehusmann","year":"2009","unstructured":"Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, Bien CG (2009) Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66:458\u2013464","journal-title":"Arch Neurol"},{"key":"796_CR32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pediatrneurol.2012.06.013","volume":"47","author":"JJ Lin","year":"2012","unstructured":"Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252\u2013258","journal-title":"Pediatr Neurol"},{"key":"796_CR33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","volume":"71","author":"M Hutchinson","year":"2008","unstructured":"Hutchinson M, Waters P, McHugh J, Gorman G, O\u2019Riordan S, Connolly S, Hager H, Yu P, Becker CM, Vincent A (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71:1291\u20131292","journal-title":"Neurology"},{"key":"796_CR34","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonzalez","year":"2014","unstructured":"Carvajal-Gonzalez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, Lang B, Pettingill P, Carr A, Sheerin UM, Press R, Lunn MP, Lim M, Maddison P, Meinck HM, Vandenberghe W, Vincent A (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137:2178\u20132192","journal-title":"Brain"},{"key":"796_CR35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejpn.2016.08.013","volume":"21","author":"DW Chan","year":"2017","unstructured":"Chan DW, Thomas T, Lim M, Ling S, Woodhall M, Vincent A (2017) Focal status epilepticus and progressive dyskinesia: a novel phenotype for glycine receptor antibody-mediated neurological disease in children. Eur J Paediatr Neurol 21:414\u2013417","journal-title":"Eur J Paediatr Neurol"},{"key":"796_CR36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","volume":"10","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10:685\u2013692","journal-title":"Nat Med"},{"key":"796_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcala C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13:276\u2013286","journal-title":"Lancet Neurol"},{"key":"796_CR38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/WNP.0b013e31829ddcdb","volume":"30","author":"M Spindler","year":"2013","unstructured":"Spindler M, Jacks LM, Chen X, Panageas K, DeAngelis LM, Avila EK (2013) Spectrum of nonconvulsive status epilepticus in patients with cancer. J Clin Neurophysiol 30:339\u2013343","journal-title":"J Clin Neurophysiol"},{"key":"796_CR39","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneur.58.8.1310","volume":"58","author":"L Cocito","year":"2001","unstructured":"Cocito L, Audenino D, Primavera A (2001) Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol 58:1310","journal-title":"Arch Neurol"},{"key":"796_CR40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0303-8467(94)90121-X","volume":"96","author":"FW Drislane","year":"1994","unstructured":"Drislane FW (1994) Nonconvulsive status epilepticus in patients with cancer. Clin Neurol Neurosurg 96:314\u2013318","journal-title":"Clin Neurol Neurosurg"},{"key":"796_CR41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"796_CR42","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","volume":"88","author":"M Spatola","year":"2017","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI, Julia Benique MR, Benson L, Gorman M, Felipe A, Caparo Oblitas RL, Rosenfeld MR, Graus F, Dalmau J (2017) Investigations in GABAA receptor antibody-associated encephalitis. Neurology 88:1012\u20131020","journal-title":"Neurology"},{"key":"796_CR43","doi-asserted-by":"publisher","unstructured":"Atmaca MM, Gurses C (2017) Status Epilepticus and multiple sclerosis: a case presentation and literature review. Clin EEG Neurosci. doi:\n                        10.1177\/1550059417693732?journalCode=eegb","DOI":"10.1177\/1550059417693732?journalCode=eegb"},{"key":"796_CR44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s13760-013-0210-x","volume":"113","author":"H Durmus","year":"2013","unstructured":"Durmus H, Kurtuncu M, Tuzun E, Pehlivan M, Akman-Demir G, Yapici Z, Eraksoy M (2013) Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurol Belg 113:421\u2013426","journal-title":"Acta Neurol Belg"},{"key":"796_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1525-5050(02)00646-7","volume":"4","author":"CM Poser","year":"2003","unstructured":"Poser CM, Brinar VV (2003) Epilepsy and multiple sclerosis. Epilepsy Behav 4:6\u201312","journal-title":"Epilepsy Behav"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-017-0796-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-017-0796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-017-0796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T11:09:56Z","timestamp":1509707396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-017-0796-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s13760-017-0796-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]}}}